title: Does intravitreal injection of ranibizumab increase the risk for macular hole formation?
authors.forename: Hans-Sebastian
authors.initials: HS
authors.lastname: Walter
authors.forename: Zisis
authors.initials: Z
authors.lastname: Gatzioufas
authors.forename: Moatasem
authors.initials: M
authors.lastname: El-Husseiny
authors.forename: Evangelos
authors.initials: E
authors.lastname: Stavridis
authors.forename: Berthold
authors.initials: B
authors.lastname: Seitz
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D005260:Female; D006801:Humans; D012163:Retinal Detachment / Q000188:drug therapy*; D012167:Retinal Perforations / Q000139:chemically induced* / Q000188:drug therapy*; D055213:Retinal Pigment Epithelium / Q000473:pathology*
chemical_list: D000911:Antibodies, Monoclonal